BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37910824)

  • 41. Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
    Nourmohammadi N; Liang THP; Sadigh G
    Clin Lung Cancer; 2024 Jun; 25(4):e189-e195.e2. PubMed ID: 38522980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
    Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
    J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing cotinine and NNAL verification of self-reported smoking status among lung cancer screening eligible population from the 2007-2014 National Health and Nutrition Examination Survey (NHANES).
    Li W; Liu B
    Biomarkers; 2021 Feb; 26(1):45-54. PubMed ID: 33210550
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk-Based lung cancer screening: A systematic review.
    Toumazis I; Bastani M; Han SS; Plevritis SK
    Lung Cancer; 2020 Sep; 147():154-186. PubMed ID: 32721652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
    Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
    Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
    Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
    Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electronic Medical Record Inaccuracies: Multicenter Analysis of Challenges with Modified Lung Cancer Screening Criteria.
    Wilshire CL; Fuller CC; Gilbert CR; Handy JR; Costas KE; Louie BE; Aye RW; Farivar AS; Vallières E; Gorden JA
    Can Respir J; 2020; 2020():7142568. PubMed ID: 32300379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of a Deep Learning-Based Model to Predict Lung Cancer Risk Using Chest Radiographs and Electronic Medical Record Data.
    Raghu VK; Walia AS; Zinzuwadia AN; Goiffon RJ; Shepard JO; Aerts HJWL; Lennes IT; Lu MT
    JAMA Netw Open; 2022 Dec; 5(12):e2248793. PubMed ID: 36576736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burden of male hardcore smokers and its characteristics among those eligible for lung cancer screening.
    Park DW; Jang JY; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Kang DR; Sohn JW
    BMC Public Health; 2020 Jan; 20(1):151. PubMed ID: 32005218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
    Potter AL; Xu NN; Senthil P; Srinivasan D; Lee H; Gazelle GS; Chelala L; Zheng W; Fintelmann FJ; Sequist LV; Donington J; Palmer JR; Yang CJ
    J Clin Oncol; 2024 Jun; 42(17):2026-2037. PubMed ID: 38537159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
    Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
    Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
    [No Abstract]   [Full Text] [Related]  

  • 53. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines.
    McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G
    Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing data availability and quality within an electronic health record system through external validation against an external clinical data source.
    Palmer EL; Higgins J; Hassanpour S; Sargent J; Robinson CM; Doherty JA; Onega T
    BMC Med Inform Decis Mak; 2019 Jul; 19(1):143. PubMed ID: 31345210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Su CT; Bhargava A; Shah CD; Halmos B; Gucalp RA; Packer SH; Ohri N; Haramati LB; Perez-Soler R; Cheng H
    Clin Lung Cancer; 2018 Sep; 19(5):e767-e773. PubMed ID: 29937386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Likelihood of Lung Cancer Screening by Poor Health Status and Race and Ethnicity in US Adults, 2017 to 2020.
    Rustagi AS; Byers AL; Keyhani S
    JAMA Netw Open; 2022 Mar; 5(3):e225318. PubMed ID: 35357450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of Lung Cancer Screening in the Veterans Health Administration.
    Kinsinger LS; Anderson C; Kim J; Larson M; Chan SH; King HA; Rice KL; Slatore CG; Tanner NT; Pittman K; Monte RJ; McNeil RB; Grubber JM; Kelley MJ; Provenzale D; Datta SK; Sperber NS; Barnes LK; Abbott DH; Sims KJ; Whitley RL; Wu RR; Jackson GL
    JAMA Intern Med; 2017 Mar; 177(3):399-406. PubMed ID: 28135352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
    Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
    Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LungCARE: Encouraging Shared Decision-Making in Lung Cancer Screening-a Randomized Trial.
    Walsh JME; Karliner L; Smith A; Leykin Y; Gregorich SE; Livaudais-Toman J; Velazquez AI; Lowenstein M; Kaplan CP
    J Gen Intern Med; 2023 Nov; 38(14):3115-3122. PubMed ID: 37653203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
    Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
    Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.